XERS - Xeris Pharmaceuticals EPS beats by $0.02 beats on revenue November, 07 2019 08:12 AM Xeris Pharmaceuticals Inc. Xeris Pharmaceuticals (NASDAQ:XERS): Q3 GAAP EPS of -$1.22 beats by $0.02.More news on: Xeris Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...